218,264 Axon Enterprise, Inc $AXON Shares Bought by Ritholtz Wealth Management

Ritholtz Wealth Management boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 10,951.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 220,257 shares of the biotechnology company’s stock after purchasing an additional 218,264 shares during the quarter. Axon Enterprise comprises about 1.3% of Ritholtz Wealth Management’s investment portfolio, making the stock its 17th largest position. Ritholtz Wealth Management owned about 0.27% of Axon Enterprise worth $93,063,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of AXON. Keel Point LLC grew its stake in shares of Axon Enterprise by 4.4% in the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock worth $254,000 after buying an additional 25 shares in the last quarter. Bridgewater Advisors Inc. raised its position in shares of Axon Enterprise by 4.4% during the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after buying an additional 26 shares in the last quarter. Pinnacle Wealth Planning Services Inc. raised its position in shares of Axon Enterprise by 7.8% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock valued at $153,000 after buying an additional 26 shares in the last quarter. 44 Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 6.0% in the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after acquiring an additional 30 shares during the last quarter. Finally, Owl Creek Wealth Partners LLC lifted its holdings in shares of Axon Enterprise by 84.8% in the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 39 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In other news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the transaction, the chief executive officer owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 37,397 shares of company stock worth $21,234,034. 4.20% of the stock is currently owned by company insiders.

Latest Axon Enterprise News

Investors following AXON have been watching these news items:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?

Wall Street Analysts Forecast Growth

Several research firms recently commented on AXON. Barclays dropped their price target on Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating for the company in a research report on Monday. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 target price for the company. in a report on Friday, November 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Tuesday, November 3rd. Finally, Argus boosted their target price on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $612.18.

Axon Enterprise Stock Up 4.3%

Shares of NASDAQ AXON opened at $315.42 on Thursday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The company has a market cap of $25.68 billion, a P/E ratio of 101.10, a PEG ratio of 5.75 and a beta of 1.48. Axon Enterprise, Inc has a 1 year low of $291.45 and a 1 year high of $665.07. The firm has a 50-day simple moving average of $426.24 and a two-hundred day simple moving average of $470.65.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.89 by ($0.17). The business had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm’s quarterly revenue was up 27.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.17 EPS. Research analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.